These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2603575)

  • 21. Human ventromesencephalic grafts restore dopamine release and clearance in hemiparkinsonian rats.
    Wang Y; Lin JC; Chiou AL; Liu JY; Liu JC; Zhou FC
    Exp Neurol; 1995 Dec; 136(2):98-106. PubMed ID: 7498419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible mechanisms of action of adrenal transplants in Parkinson's disease.
    Drucker-Colín R; García-Hernández F; Mendoza-Ramírez JL; Pacheco-Cano MT; Komisaruk BR
    Prog Brain Res; 1990; 82():509-14. PubMed ID: 1963226
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuropathology of fetal nigral grafts in patients with Parkinson's disease.
    Kordower JH; Freeman TB; Olanow CW
    Mov Disord; 1998; 13 Suppl 1():88-95. PubMed ID: 9613724
    [No Abstract]   [Full Text] [Related]  

  • 24. Nigral and adrenal grafts in parkinsonism: recent basic and clinical studies.
    Olson L; Backlund EO; Gerhardt G; Hoffer B; Lindvall O; Rose G; Seiger A; Strömberg I
    Adv Neurol; 1987; 45():85-94. PubMed ID: 3030073
    [No Abstract]   [Full Text] [Related]  

  • 25. Catecholamine content of intracerebral adrenal medulla grafts.
    Freed WJ; Karoum F; Spoor HE; Morihisa JM; Olson L; Wyatt RJ
    Brain Res; 1983 Jun; 269(1):184-9. PubMed ID: 6683581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catecholamine-containing grafts in parkinsonism: past and present.
    Hoffer BJ; Granholm AC; Stevens JO; Olson L
    Clin Res; 1988 Apr; 36(3):189-95. PubMed ID: 3286096
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical neuromythology X. Faithful fashion: survival status of the brain transplant cure for parkinsonism.
    Landau WM
    Neurology; 1993 Apr; 43(4):644-9. PubMed ID: 8469316
    [No Abstract]   [Full Text] [Related]  

  • 28. [Neurotransplantation in Parkinson disease: experimental and clinical results of functional reconstruction of the dopaminergic system].
    Nikkhah G; Brandis A
    Zentralbl Neurochir; 1995; 56(4):153-60. PubMed ID: 8571693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Grafts correct brain damage.
    Kolata G
    Science; 1982 Jul; 217(4557):342-4. PubMed ID: 7089568
    [No Abstract]   [Full Text] [Related]  

  • 30. [Adrenal transplantation and Parkinson's disease].
    Luquin MR; Legarda I; Guillén J; Rodríguez MC; Martínez-Lage JM
    Rev Med Univ Navarra; 1994; 38(4):174-80. PubMed ID: 8992595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of central nervous system plasticity.
    Psychopharmacol Bull; 1983; 19(3):305-16. PubMed ID: 6635111
    [No Abstract]   [Full Text] [Related]  

  • 32. [Simultaneous micro-transplantation of fetal mesencephalic cells to the striate and substantia nigra pars reticulata in hemi-parkinsonian rats. A study of behavior].
    Blanco L; Pavón N; Macías R; Castillo L; Díaz C; García A; Alvarez P
    Rev Neurol; 2000 Jun 16-30; 30(12):1122-7. PubMed ID: 10935235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fetal and adrenal transplantation in Parkinson disease: theoretical bases and clinical results].
    Diederich NJ; Goetz CG
    Bull Soc Sci Med Grand Duche Luxemb; 1993; 130(1):25-36. PubMed ID: 8222013
    [No Abstract]   [Full Text] [Related]  

  • 34. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
    [No Abstract]   [Full Text] [Related]  

  • 35. Adrenal chromaffin cells as transplants in animal models of Parkinson's disease.
    Hansen JT; Bing GY; Notter MF; Kordower JH; Fiandaca MS; Gash DM
    J Electron Microsc Tech; 1989 Aug; 12(4):308-15. PubMed ID: 2671302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of intracerebral transplantation of immature substantia nigra in rats with experimentally induced Parkinson's disease. II. Results of histopathological and histofluorescent studies.
    Dymecki J; Półtorak M; Puciłowski O; Markiewicz D; Kostowski W
    Neuropatol Pol; 1985; 23(2):181-9. PubMed ID: 3930995
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intraparenchymal and intraventricular transplantation of fetal substantia nigra cell suspension in rat model of Parkinson's disease].
    Yang H; Zhang K; Cai W
    Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):19-21. PubMed ID: 10374501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long-term survival of fetal substantia nigra grafts in striatum of PD rats: an observation of tyrosine hydroxylase immunohistochemistry and western blot].
    Yang H; Cai W; Zhang K
    Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):13-5. PubMed ID: 10374499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between animal models and clinical parkinsonism.
    Marsden CD; Duvoisin RC; Jenner P; Parkes JD; Pycock C; Tarsy D
    Adv Neurol; 1975; 9():165-75. PubMed ID: 1146651
    [No Abstract]   [Full Text] [Related]  

  • 40. Transplantation of cultured human adrenal chromaffin cells into 6-hydroxydopamine-lesioned rat brain.
    Kamo H; Kim SU; McGeer PL; Tago H; Shin DH
    Synapse; 1987; 1(4):324-8. PubMed ID: 2901789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.